Biopharma launch performance is often measured against the yardstick of analysts’ forecasts. In this webinar, ZS launch and forecasting experts Ben Hohn, Komal Gurnani and Jeremy Rudy review recent trends with respect to launch performance, including a spotlight on how emerging biopharma first launches actually fared over a five-year period compared to analyst expectations at the time of launch. They also share highlights from research that considers what really drives launch success, as well as recent research on the importance of customer retention.
In this webinar, you’ll learn about:
- What analyst predictions get wrong
- Why customer retention and focus on repeat customers merits specific emphasis
- The importance of more integrated customer engagement models